echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Long-term sequelae of COVID-19 may stem from an overactive immune response in the lungs

    Long-term sequelae of COVID-19 may stem from an overactive immune response in the lungs

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    When healthy, the immune system is usually dormant in the lungs


    Shortly after the COVID-19 pandemic began, there were some anecdotal reports that previously healthy people had persistent symptoms and were not fully recovering


    Viruses that cause respiratory illnesses such as the flu and COVID-19 can cause mild to severe symptoms


    The University of Virginia studies how the immune system sometimes goes wrong after fighting a viral infection


    People with long COVID-19 may experience persistent respiratory, cognitive, and neurologic symptoms


    Health and disease of the lungs

    In order for your lungs to work optimally, it is crucial that your immune system remains dormant when there is no active infection


    There are many names for post-COVID-19 symptoms, including: long COVID-19, chronic COVID-19, acute post-COVID-19, long-term effects of COVID-19, acute sequelae of SARS CoV-2 infection (PASC), and long-term COVID-19


    Your airways are in constant contact with the outside world, inhaling about 5-8 liters (1.


    However, during an active infection, the immune system is absolutely necessary


    An overactive immune system, such as asthma, can damage the lungs


    Over the past decade, scientists have discovered a variety of special stem cells in the lungs that can help damaged tissue regenerate


    While the cause is unknown, some people are unable to shut down their immune systems after infection and continue to produce tissue-destroying molecules


    So far, researchers have identified a specific type of immune cell, killer T cells, as potential contributors


    During active infection, killer T cells are essential


    A large number of immune cells work together to clear out invading pathogens


    Another type of immune cell, called monocytes, is also involved in fighting respiratory infections, becoming first responders by producing viral and tissue-damaging cytokines


    Understanding the long-standing immune mechanisms of COVID-19 is the first step
    in addressing rapidly worsening public health problems.
    Identifying subtle differences in how protecting your immune cells later become harmful during an active infection can help diagnose prolonged COVID-19
    .
    In addition, according to the findings, treatment against the immune system may be an effective way
    to manage the long symptoms of COVID-19.
    This strategy may be useful not only for COVID-19, but also for other respiratory viral infections that cause chronic disease
    .

    The author is Harish Narasimhan, a Ph.
    D.
    candidate in
    immunology at the University of Virginia.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.